Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combination Product Designations At US FDA Need Faster Appeals, Petition Says

Executive Summary

No sponsor is named in the citizen petition, but it was filed on behalf of an applicant that has had an appeal of a designation decision 'under consideration' for 18 months and counting.

Advertisement

Related Content

FDA Final Guidance On Drug/Device Classifications Misses The Mark, Attorneys Say
Combo Product Appeals Low In Number, But Lengthy In Decision Time
Combo Products Won't Get Special Review Pathway At US FDA Anytime Soon
Combo Product Consultations At US FDA May Suffer As They Become Formalized
Combo Product Review Pilot At US FDA Will Offer All Applications Intercenter Consults
Ball In Judge’s Court In Combination Product Classification Suit

Topics

Advertisement
UsernamePublicRestriction

Register

PS120199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel